Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab

George P Kim, Axel GrotheyCollege of Medicine, Mayo ClinicAbstract: The human anti-epidermal growth factor receptor (EGFR) monoclonal antibody, panitumumab, represents a significant advance in the treatment of colorectal cancer. The strategy to target this receptor is based on sound cancer biology d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: George P Kim, Axel Grothey
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://doaj.org/article/57281556fa324096a7bb22e95eedc8df
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!